- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare HDFC Pharma And Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.07 | 1.93 |
NAV | ₹16.43 | ₹422.08 |
Fund Started | 14 Sep 2023 | 04 Jun 1999 |
Fund Size | ₹1704.87 Cr | ₹3689.28 Cr |
Exit Load | Exit load of 1%, if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.07
1.93
NAV
₹16.43
₹422.08
Fund Started
14 Sep 2023
04 Jun 1999
Fund Size
₹1704.87 Cr
₹3689.28 Cr
Exit Load
Exit load of 1%, if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 24.44% | 17.16% |
3 Year | - | 29.50% |
5 Year | - | 23.61% |
1 Year
24.44%
17.16%
3 Year
-
29.50%
5 Year
-
23.61%
Holding Analysis
Equity | 99.21% | 96.09% |
Cash | 0.79% | 3.83% |
Equity
99.21%
96.09%
Cash
0.79%
3.83%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.25% |
Divi's Laboratories Ltd. | 10.24% |
Cipla Ltd. | 7.00% |
Lupin Ltd. | 5.59% |
Max Healthcare Institute Ltd. | 4.83% |
Glenmark Pharmaceuticals Ltd. | 4.12% |
Ipca Laboratories Ltd. | 3.99% |
Krishna Institute of Medical Sciences Ltd | 3.95% |
Aster DM Healthcare Ltd. | 3.92% |
Eris Lifesciences Ltd. | 3.54% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.73% |
Divi's Laboratories Ltd. | 7.39% |
Max Healthcare Institute Ltd. | 6.40% |
Lonza Group Ag | 4.81% |
Cipla Ltd. | 4.77% |
Lupin Ltd. | 4.46% |
Mankind Pharma Ltd. | 3.75% |
Krishna Institute of Medical Sciences Ltd | 3.34% |
Fortis Healthcare Ltd. | 3.22% |
Acutaas Chemicals Ltd. | 3.19% |
Fund Manager
Name | Dhruv Muchhal | Tanmaya Desai |
Start Date | 14 Sep 2023 | 27 Jun 2011 |
Name
Dhruv Muchhal
Tanmaya Desai
Start Date
14 Sep 2023
27 Jun 2011
About Fund
Description | The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 14 Sep 2023 | 04 Jun 1999 |
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
14 Sep 2023
04 Jun 1999